NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 6.14% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.94% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.98% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 4.90% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.83% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.58% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.55% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.46% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.41% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 4.16% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.13% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.57% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.55% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.40% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.39% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |